Modern trends in the treatment of endometriosis

Condition tags

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (35)

• A dose‐ranging study to determine the efficacy and safety of 1, 2, and 4 mg of dienogest daily for endometriosis via openalex
• Advances in the management of endometriosis: an update for clinicians via openalex
• Angiogenesis lymphangiogenesis and neurogenesis in endometriosis via openalex
• Changes in quality of life after hormonal treatment of endometriosis via openalex
• Clinical Management of Endometriosis via openalex
• Clinical Management of Endometriosis via openalex
• Dienogest via openalex
• Dienogest: an oral progestogen for the treatment of endometriosis via openalex
• Dienogest inhibits nerve growth factor expression induced by tumor necrosis factor-α or interleukin-1β via openalex
• Dienogest is as effective as intranasal buserelin acetate for the relief of pain symptoms associated with endometriosis—a randomized, double-blind, multicenter, controlled trial via openalex
• Dienogest reduces HSD17β1 expression and activity in endometriosis via openalex
• Effects of dienogest, a synthetic steroid, on experimental endometriosis in rats via openalex
• Endometriosis via openalex
• Endometriosis in Adolescence via openalex
• Endometriosis: ways of the decision of a problem to the XXI century via openalex
• Examination: Endometriosis—A Missed Malady via openalex
• Health-Related Quality of Life Burden for Women With Endometriosis via openalex
• Inflammation and nerve fiber interaction in endometriotic pain via openalex
• Nuclear Factor-κB (NF-κB): An Unsuspected Major Culprit in the Pathogenesis of Endometriosis That Is Still at Large? via openalex
• Pelvic Pain and Quality of Life of Women With Endometriosis During Quadriphasic Estradiol Valerate/Dienogest Oral Contraceptive: A Patient-Preference Prospective 24-Week Pilot Study via openalex
• Progesterone and progestational compounds attenuate tumor necrosis factor alpha–induced interleukin-8 production via nuclear factor kappaB inactivation in endometriotic stromal cells via openalex
• Reprint of Classification and pharmacology of progestins via openalex
• The dynamics of nuclear receptors and nuclear receptor coregulators in the pathogenesis of endometriosis via openalex
• The use of newer progestins for contraception via openalex
• Vitamin D and endometriosis: looking for new opportunities via openalex
• W1975901041 via openalex
• W2021687464 via openalex
• W2085922363 via openalex
• W2101417341 via openalex
• W2104687197 via openalex
• W2123134517 via openalex
• W2130203785 via openalex
• W2089800651 via openalex
• W2017153578 via openalex
• W2395874862 via openalex

Cited by (8)

• Use of gonadotropic releasing hormone agonists in hyperplastic syndrome in gynecology 2025
• Practical aspects of endometriosis treatment in patients of reproductive age 2025
• Experience with the use of amitriptyline for chronic pelvic pain associated with endometriosis 2025
• Pathogenetic aspects of chronic pelvic pain in endometriosis: diagnostic prospects (literature review) 2024
• Evaluation of the effectiveness of dienogest in the treatment of chronic pelvic pain in patients with endometriosis 2023
• Opportunities to improve the effectiveness of complex therapy for endometriosis and chronic pelvic pain in patients of reproductive age 2023
• Immunological comorbidity of adenomyosis and the possibility of its correction 2022
• Endometriosis in adolescents (a review) 2022

Source provenance

openalex

last seen: 2026-06-10T17:14:06.276822+00:00

unpaywall

last seen: 2026-06-02T02:00:03.124865+00:00